4//SEC Filing
Sandercock Colin 4
Accession 0001209191-22-021456
CIK 0001645460other
Filed
Mar 28, 8:00 PM ET
Accepted
Mar 29, 4:13 PM ET
Size
7.6 KB
Accession
0001209191-22-021456
Insider Transaction Report
Form 4
Sandercock Colin
SVP, GENERAL COUNSEL
Transactions
- Award
Stock Option (right to buy)
2022-03-25+16,667→ 16,667 totalExercise: $5.01Exp: 2032-03-24→ Common Stock (16,667 underlying) - Award
Stock Option (right to buy)
2022-02-09+60,000→ 60,000 totalExercise: $6.91Exp: 2032-02-08→ Common Stock (60,000 underlying)
Footnotes (2)
- [F1]1. This stock option grant becomes exercisable in eight equal semi-annual installments beginning August 9, 2022.
- [F2]2. This stock option grant becomes exercisable in eight equal semi-annual installments beginning September 25, 2022.
Documents
Issuer
Cue Biopharma, Inc.
CIK 0001645460
Entity typeother
Related Parties
1- filerCIK 0001724870
Filing Metadata
- Form type
- 4
- Filed
- Mar 28, 8:00 PM ET
- Accepted
- Mar 29, 4:13 PM ET
- Size
- 7.6 KB